Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC.
Swick AD, Prabakaran PJ, Miller MC, Javaid AM, Fisher MM, Sampene E, Ong IM, Hu R, Iida M, Nickel KP, Bruce JY, Wheeler DL, Kimple RJ.
Swick AD, et al. Among authors: miller mc.
Mol Cancer Ther. 2017 Jul;16(7):1257-1268. doi: 10.1158/1535-7163.MCT-17-0115. Epub 2017 Apr 26.
Mol Cancer Ther. 2017.
PMID: 28446642
Free PMC article.